Irinotecan (40mg)
Torsirin 40mg Injection is used in the treatment of ovarian cancer, small cell lung cancer, cervical cancer and
2 ml in 1 vial
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Torsirin 40mg Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase I) involved in DNA multiplication of the cancer cells. This slows the growth of cancer cells and eventually kills them.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Torsirin 40mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your d
Torsirin 40mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Torsirin 40mg Injection may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Torsirin 40mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Torsirin 40mg Injection may not be needed in these patients. Please consult your doctor.
Use of this medicine is no
There is limited information available on the use of Torsirin 40mg Injection in patients with liver disease. Please consult your doctor.
